Security key
877619106
TAYSHA GENE THERAPIES, INC. - Common Stock, $0.00001 par value per share (TSHA)
CUSIP: 877619106
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, $0.00001 par value per share
- Total 13F shares
- 264,720,110
- Total 13F value
- $1,182,044,534
- Share change
- -3,254,161
- Put/Call ratio
- 25%
- SEC-reported price per share
- $4.47
- Number of holders
- 187
- Value change
- -$21,469,003
- Number of buys
- 92
- Number of sells
- 83
- Shares outstanding
- 332,184,263
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
187
Top holders
10
TSHA full security history
Ownership snapshot
Full 13F holder table
Taysha Gene Therapies, Inc. SEC filings
Taysha Gene Therapies, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TSHA - TAYSHA GENE THERAPIES, INC. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Paul B. Manning
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 9.8%
13D/G row: Paul B. Manning
Showing 1-6 of 15 holder rows.
Quick read
Paul B. Manning leads the comparable SEC ownership view at 9.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Paul B. Manning's linked filing trail.
Comparable ownership
Top 5
Paul B. Manning
9.8%
RTW INVESTMENTS, LP
7%
BlackRock, Inc.
6.5%
Vestal Point Capital, LP
6.3%
GOLDMAN SACHS GROUP INC
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Paul B. Manning |
13D/G
3/4/5
10%+ Owner
|
9.8%
|
$59,394,578
25,601,111 shares
|
$0 | 30 May 2025 |
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
7%
|
$92,480,205
20,689,084 shares
|
-$12,149,679 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.5%
from 13D/G
|
$102,537,212
18,643,129 shares
|
— | 31 Dec 2025 |
| Vestal Point Capital, LP |
13D/G
13F
Company
|
6.3%
|
$80,460,000
18,000,000 shares
|
+$18,997,500 | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13F
13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
|
5.1%
from 13D/G
|
$75,310,065
13,692,739 shares
|
— | 31 Dec 2025 |
| FMR LLC |
13D/G
13F
Company
|
4.9%
|
$74,406,012
13,528,366 shares
|
-$11,547,008 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
187
Shares
264,720,110
Rows available
187
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
187
Q1 2026 holders
187
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|